But some of the index's components haven't fared so well. Two well-known stocks in the DJIA have collapsed in value through ...

According to the S&P Dow Jones Indices, U.S. common dividend increases were $9.8 billion in the second quarter of 2025, down ...

Wedgewood Partners, an investment management company, released its second-quarter 2025 investor letter. A copy of the letter ...

Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” second-quarter ...

UnitedHealth Group Incorporated (NYSE:UNH) is one of the Most Undervalued High Quality Stocks to Buy According to Hedge Funds ...

UnitedHealth stock is deeply oversold, undervalued, and primed for a recovery. Read why analysts forecast UNH to have a ~29% ...

Investors soured on the sector when Elevance, an insurer, handed in disappointing results and shared a downbeat outlook.

Shares of Elevance Health Inc. tumbled toward a more than four-year low Thursday, after the health insurer slashed its full-year profit outlook and said pressures from rising Medicaid and Obamacare ...

UnitedHealth Group remains a dominant force within the U.S. healthcare landscape, with a market capitalization of $272.7 billion. The company operates through its two primary arms, UnitedHealthcare ...

UnitedHealth delays Q2 report to July 29 as insurer earnings season begins with cost pressures clouding 2025 outlooks across ...

Shares have cratered since April, when the company slashed its financial guidance and posted earnings that missed ...

Wolfe Research reaffirmed its ‘Outperform’ rating on UnitedHealth Group but cut its price target to $330 from $363, citing ongoing medical billing pressures. The firm highlighted that UnitedHealth’s ...